Angela Tembo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Angela Tembo

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

BMC Infectious Diseases|February 25, 2025

Reaching priority populations with different HIV self-testing distribution models in South Africa: an analysis of programme dataMohammed Majam, Karin Hatzold, Webster Mavhu, et al.

Frontiers in Reproductive Health|October 4, 2023

Risks of metabolic syndrome in the ADVANCE and NAMSAL trialsTamara Tovar Sanchez, Mireille Mpoudi-Etame, Charles Kouanfack, et al.

Open Forum Infectious Diseases|March 26, 2024

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral RegimensSimiso Sokhela, Willem D F Venter, Bronwyn Bosch, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

BMC Infectious Diseases|February 25, 2025

Reaching priority populations with different HIV self-testing distribution models in South Africa: an analysis of programme dataMohammed Majam, Karin Hatzold, Webster Mavhu, et al.

Frontiers in Reproductive Health|October 4, 2023

Risks of metabolic syndrome in the ADVANCE and NAMSAL trialsTamara Tovar Sanchez, Mireille Mpoudi-Etame, Charles Kouanfack, et al.

Open Forum Infectious Diseases|March 26, 2024

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral RegimensSimiso Sokhela, Willem D F Venter, Bronwyn Bosch, et al.

Pageof 2